Jan 31, 2025 09:01AM
Jan 31, 2025 09:00AM
Jun 13, 2023 09:01AM
Jun 5, 2023 09:00AM
May 15, 2023 05:37AM
Apr 17, 2023 09:02AM
Apr 17, 2023 09:00AM Scilex Holding Company Enters into Master Distributor Agreement with CH Trading Group LLC and AD Ports Group for the Distribution of ZTlido® in the Middle East and North Africa Region
Apr 14, 2023 06:32PM
Apr 5, 2023 05:27PM
Apr 4, 2023 01:51PM
Mar 27, 2023 09:00AM
Mar 21, 2023 09:00AM
Mar 8, 2023 10:14AM
Mar 8, 2023 10:13AM Scilex Holding Company and CH Trading Group Announce Territory Distribution Agreement to Expand Commercialization of ZTlido® for the Middle East and North Africa (MENA) With $105 Million Minimum Mult
Feb 27, 2023 09:02AM
Feb 27, 2023 09:00AM
Feb 22, 2023 05:46AM
Feb 21, 2023 05:57PM
Feb 18, 2023 08:37PM
Feb 16, 2023 02:42PM
Feb 16, 2023 02:41PM Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions
Feb 13, 2023 03:46PM
Feb 4, 2023 10:48PM
Feb 3, 2023 08:59PM
Feb 2, 2023 02:12PM
Feb 2, 2023 01:15PM
Jan 29, 2023 10:26PM
Jan 29, 2023 09:55PM Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
Jan 9, 2023 09:01AM
Jan 9, 2023 09:00AM
Dec 6, 2022 09:01AM
Dec 6, 2022 09:00AM
Dec 5, 2022 03:01PM
Dec 5, 2022 03:01PM
Nov 29, 2022 02:07PM Sorrento (SRNE) Releases Positive Topline Results from Phase I Study Completed in Australia and Preliminary Results from Phase Ib Study in China with STI-1558
Nov 29, 2022 02:06PM
Nov 13, 2022 03:02PM
Nov 10, 2022 02:45PM
Nov 10, 2022 02:15PM
Oct 31, 2022 09:01AM
Oct 31, 2022 09:00AM
Oct 26, 2022 07:00AM Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Present
Oct 17, 2022 09:00AM
Oct 14, 2022 02:58PM
Oct 14, 2022 02:56PM
Oct 6, 2022 09:00AM
Sep 29, 2022 09:00AM
Sep 26, 2022 09:00AM
Sep 15, 2022 03:34PM Sorrento Therapeutics (SRNE) Announces Publication in Nature Journal Scientific Reports the Details of the Discovery of SARS-CoV-2 Neutralizing Antibodies from the G-MAB Library
Sep 15, 2022 03:34PM

322,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All